Evidence map›Paper›PMID 33076350›Full record

ArticleGenes2020

Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with

John Jorholt, Yulia Formicheva, Tatyana Vershinina, Artem Kiselev, Alexey Muravyev, Elena Demchenko, Petr Fedotov, Anna Zlotina, Anton Rygkov, Elena Vasichkina and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Novel compound heterozygousFrontiers in cardiovascular medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. A novel compound heterozygous variant inFrontiers in cardiovascular medicine · 2023
    Article
  8. Overlapping Phenotype of Adult-OnsetCardiology research · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Understanding the molecular basis of cardiomyopathy.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  13. Article
  14. Case Report: Loss-of-FunctionFrontiers in genetics · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genes · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

John JorholtDepartment of Women's and Children's Health and Center for Molecular Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Yulia FormichevaAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Tatyana VershininaAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Artem KiselevAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Alexey MuravyevAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Elena DemchenkoAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Petr FedotovAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Anna ZlotinaAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Anton RygkovAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Elena VasichkinaAlmazov National Medical Research Centre, Saint Petersburg 197341, Russia.
Thomas SejersenDepartment of Women's and Children's Health and Center for Molecular Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Anna KostarevaDepartment of Women's and Children's Health and Center for Molecular Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Federal Almazov North-West Medical Research Centre · RUKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic cardiomyopathy associated with damaging variants in the

Indexed as

HeterozygoteHomozygoteMutationAdultAge of OnsetCardiomyopathy, HypertrophicExome SequencingFemaleHumansInfant, NewbornMaleMuscle ProteinsMuscle, SkeletalPhenotypeProtein KinasesYoung AdultAlpk3 protein, humanMuscle ProteinsProtein Kinasesalpha kinase 3ALPK3hypertrophic cardiomyopathy

Identifiers

PMID33076350
PMCPMC7602582
OpenAlexW3092753281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.